SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: W Shakespeare who wrote (1406)12/7/1999 8:55:00 AM
From: MGV   of 1754
 
By Tomi Kilgore & Brenon Daly, CBS MarketWatch
Last Update: 8:22 AM ET Dec 7, 1999 NewsWatch
Market Pulse

NEW YORK (CBS.MW) -- Visx, Inc. saw its shares get pummeled in pre-market trading Tuesday after the International Trade Commission ruled that a competitor did not violate the Tariff Act of 1930.


Today on CBS MarketWatch
Stocks look to mixed open
News Corp., Healtheon in $1 bln partnership
U.S. view of Microsoft antitrust violations
BT to offer unlimited Net access at a fixed price
Sun to announce new software for Java program
More top stories...
CBS MarketWatch Columns
Updated:
12/7/99 8:36:52 AM ET



Visx (VISX: news, msgs) plunged 20 1/8, or 23 percent, to 68, according to Art Hogan, chief market analyst at Jefferies & Co. The ITC said in an "initial determination" that Nidek Co., and its U.S. subsidiaries was not in violation. Visx, which develops refractive laser technology for use in eye surgery, plans to file a petition with the ITC for a full review. If the review is granted, a final determination will be issued on March 6, 2000. Nidek is a privately held Japanese company that imports lasers into the United States.

On Oct. 14, Advest Inc. analyst Theodore Huber conveyed his concerns on the impending ITC ruling on Nidek. The stock dropped 9.6 percent from the 80 21/32 level that day despite topping analyst earnings estimates. See related story.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext